Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Assess Recombinant Human Antithrombin in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
This study has been completed.
Study NCT00056550   Information provided by GTC Biotherapeutics
First Received: March 17, 2003   Last Updated: January 30, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hereditary Antithrombin Deficiency
Additional conditions recognized in this trial
Antithrombin III Deficiency
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Blood Protein Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Thrombophilia
Interventions listed in this trial
Recombinant Human Antithrombin
Additional drug interventions recognized in this trial
Antithrombin III
More general drug interventions related to this trial
Anticoagulants
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Serine Proteinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
GTC Biotherapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services